News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56,670 Results
Type
Article (1847)
Company Profile (22)
Press Release (54801)
Section
Business (26393)
Career Advice (45)
Deals (3605)
Drug Delivery (1)
Drug Development (5424)
Employer Resources (3)
FDA (1013)
Job Trends (1244)
News (35075)
Policy (1953)
Tag
Academia (85)
Accelerated approval (2)
Allergies (6)
Alliances (2297)
ALS (3)
Alzheimer's disease (72)
Antibody-drug conjugate (ADC) (14)
Approvals (1049)
Artificial intelligence (18)
Autoimmune disease (8)
Automation (3)
Bankruptcy (8)
Best Places to Work (1183)
BIOSECURE Act (1)
Biosimilars (6)
Biotechnology (15)
Bladder cancer (22)
Brain cancer (1)
Breast cancer (54)
Cancer (376)
Cardiovascular disease (31)
Career advice (33)
CAR-T (22)
CDC (1)
Cell therapy (45)
Cervical cancer (3)
Clinical research (4893)
Collaboration (68)
Company closure (1)
Compensation (65)
Complete response letters (2)
COVID-19 (122)
CRISPR (4)
C-suite (7)
Cystic fibrosis (10)
Data (518)
Depression (11)
Diabetes (28)
Diagnostics (640)
Digital health (2)
Drug discovery (5)
Drug pricing (6)
Duchenne muscular dystrophy (6)
Earnings (24477)
Editorial (3)
Employer branding (1)
Employer resources (2)
Events (5064)
Executive appointments (16)
FDA (1365)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (3)
Funding (48)
Gene editing (8)
Generative AI (2)
Gene therapy (26)
GLP-1 (60)
Government (145)
Grass and pollen (1)
Guidances (236)
Healthcare (1570)
HIV (2)
IgA nephropathy (4)
Immunology and inflammation (20)
Indications (6)
Infectious disease (140)
Inflammatory bowel disease (7)
Inflation Reduction Act (1)
Influenza (10)
Intellectual property (14)
Interviews (4)
IPO (2671)
IRA (2)
Job creations (105)
Job search strategy (32)
JPM (3)
Kidney cancer (3)
Labor market (6)
Layoffs (23)
Legal (428)
Liver cancer (2)
Lung cancer (42)
Lymphoma (46)
Management (1)
Manufacturing (20)
MASH (12)
Medical device (1363)
Medtech (1370)
Mergers & acquisitions (1010)
Metabolic disorders (70)
Multiple sclerosis (10)
NASH (3)
Neurodegenerative disease (10)
Neuropsychiatric disorders (10)
Neuroscience (137)
NextGen: Class of 2026 (375)
Non-profit (167)
Now hiring (6)
Obesity (31)
Opinion (6)
Ovarian cancer (24)
Pain (8)
Pancreatic cancer (21)
Parkinson's disease (15)
Partnered (1)
Patents (27)
Patient recruitment (18)
Peanut (1)
People (1804)
Pharmaceutical (4)
Pharmacy benefit managers (3)
Phase 1 (1234)
Phase 2 (1950)
Phase 3 (1963)
Pipeline (1175)
Policy (6)
Postmarket research (256)
Preclinical (496)
Press Release (1)
Prostate cancer (10)
Psychedelics (1)
Radiopharmaceuticals (20)
Rare diseases (46)
Real estate (259)
Recruiting (1)
Regulatory (1570)
Reports (8)
Research institute (91)
Resumes & cover letters (8)
Rett syndrome (2)
RSV (3)
Schizophrenia (7)
Series A (6)
Series B (2)
Service/supplier (1)
Sickle cell disease (9)
Special edition (4)
Spinal muscular atrophy (5)
Startups (160)
Stomach cancer (1)
Supply chain (1)
Tariffs (1)
Vaccines (60)
Venture capital (5)
Weight loss (18)
Women's health (6)
Date
Today (11)
Last 7 days (53)
Last 30 days (139)
Last 365 days (3211)
2026 (188)
2025 (3263)
2024 (3638)
2023 (4372)
2022 (4731)
2021 (5452)
2020 (4243)
2019 (3390)
2018 (2744)
2017 (2255)
2016 (1639)
2015 (2217)
2014 (1407)
2013 (779)
2012 (1022)
2011 (1188)
2010 (1156)
Location
Africa (41)
Alabama (5)
Alaska (1)
Arizona (16)
Asia (3453)
Australia (937)
California (1248)
Canada (281)
China (67)
Colorado (67)
Connecticut (46)
Delaware (37)
Europe (7147)
Florida (167)
Georgia (38)
Idaho (7)
Illinois (70)
India (11)
Indiana (70)
Japan (33)
Kansas (10)
Kentucky (3)
Louisiana (7)
Maine (11)
Maryland (129)
Massachusetts (867)
Michigan (39)
Minnesota (62)
Missouri (17)
Montana (4)
Nevada (11)
New Hampshire (9)
New Jersey (357)
New Mexico (1)
New York (299)
North Carolina (160)
Northern California (624)
Ohio (23)
Oklahoma (2)
Pennsylvania (230)
Puerto Rico (1)
South America (55)
South Carolina (1)
Southern California (504)
Tennessee (16)
Texas (189)
United States (4332)
Utah (41)
Virginia (13)
Washington D.C. (19)
Washington State (131)
Wisconsin (18)
56,670 Results for "98".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Myocardial Ischemia Market to Reach US$ 7.98 Billion by 2032, Driven by Rising Cardiovascular Disease Burden
January 13, 2026
·
1 min read
Press Releases
Diagnostic Testing Market Size Reaches New Heights: Forecast to Reach USD 272.98 Billion by 2034 Driven by Advanced Screening Technologies and Point-of-Care Expansion
December 1, 2025
·
1 min read
Press Releases
Diagnostic Testing Market Size Worth USD 272.98 Billion by 2034 Fueled by NGS and Personalized Healthcare Demand
July 1, 2025
·
1 min read
Earnings
Zepbound Topples Sales King Keytruda as Lilly Reports 54% YoY Revenue Rise for Q3
Mounjaro and Zepbound contributed more than $10 billion to the $11.98 billion in sales Lilly recorded for key products in the third quarter, despite price decreases for the GLP-1 medicines.
October 30, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
DNA Synthesis Market Size to Surpass USD 29.98 Billion By 2034
February 26, 2025
·
1 min read
Press Releases
Diagnostic Testing Market Sie to Surge USD 272.98 Billion by 2034
February 19, 2025
·
1 min read
Lipid Nanoparticles Market Anticipated to Surge to US$ 2,387.98 Million by 2032
The global lipid nanoparticles market revenue reached US$ 820.51 million in 2023 and is estimated to reach a market valuation of US$ 2,387.98 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 12.6% during the forecast period from 2024 to 2032.
May 29, 2024
·
8 min read
Press Releases
Syndax Presents New Revuforj® (revumenib) Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial at EHA 2025
June 12, 2025
·
16 min read
Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top guarantors - subscription rate in TO 2 of 98%
Moberg Pharma announces that 17,776,856 warrants of series 2023:1 were exercised for subscription of in total 17,776,856 ordinary shares for approximately SEK 320 million, corresponding to a subscription rate of approximately 98%.
June 24, 2024
·
6 min read
Press Releases
Adenoma Market Expected to Grow at a CAGR of 3.98% during 2025-2035, Impelled by Advancements in Screening and Diagnostic Techniques
January 22, 2025
·
7 min read
1 of 5,667
Next
